Parainfluenza Viruses

Principles and Practice of Pediatric Infectious Diseases, Fourth Edition

Volumn , Issue , 2012, Pages 1121-1124.e4

  Mejías, Asunción ^a,b   Ramilo, Octavio ^c,d  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84966770488     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-2702-9.00225-7     Document Type: Chapter

References (127)

1. RM Chanock and RH Parrott (1965) Acute respiratory disease in infancy and childhood: present understanding and prospects for prevention. Pediatrics 36 21-39.
2. P Glezen and FW Denny (1973) Epidemiology of acute lower respiratory disease in children. N Engl J Med 288 498-505.
3. GA Weinberg, CB Hall, MK Iwane, et al. (2009) Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. J Pediatr 154 694-699.
4. J Treanor and A Falsey (1999) Respiratory viral infections in the elderly. Antiviral Res 44 79-102.
5. AR Falsey and EE Walsh (2006) Viral pneumonia in older adults. Clin Infect Dis 42 518-524.
6. G Reed, PH Jewett, J Thompson, et al. (1997) Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5 years old. J Infect Dis 175 807-813.
7. ME Counihan, DK Shay, RC Holman, et al. (2001) Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States. Pediatr Infect Dis J 20 646-653.
8. RE Blount Jr, JA Morris and RE Savage (1956) Recovery of cytopathogenic agent from chimpanzees with coryza. Proc Soc Exp Biol Med 92 544-549.
9. KJ Henrickson and LL Savatski (1996) Two distinct human parainfluenza virus type 1 genotypes detected during the 1991 Milwaukee epidemic. J Clin Microbiol 34 695-700.
10. SK Lau, KS Li, KY Chau, et al. (2009) Clinical and molecular epidemiology of human parainfluenza virus 4 infections in Hong Kong: subtype 4B as common as subtype 4A. J Clin Microbiol 47 1549-1552.
11. BG van den Hoogen, JC de Jong, J Groen, et al. (2001) A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7 719-724.
12. KT Wong, WJ Shieh, SR Zaki and CT Tan (2002) Nipah virus infection: an emerging paramyxoviral zoonosis. Springer Semin Immunopathol 24 215-228.
13. RA Karron and PL Collins (Eds) (2007) Parainfluenza Viruses Philadelphia: Williams and Wilkins
14. RH Parrott, A Vargosko, A Luckey, et al. (1959) Clinical features of infection with hemadsorption viruses. N Engl J Med 260 731-738.
15. PP Massion, CC Funari, I Ueki, et al. (1993) Parainfluenza (Sendai) virus infects ciliated cells and secretory cells but not basal cells of rat tracheal epithelium. Am J Respir Cell Mol Biol 9 361-370.
16. R Vainionpaa and T Hyypia (1994) Biology of parainfluenza viruses. Clin Microbiol Rev 7 265-275.
17. K McIntosh (1991) Pathogenesis of severe acute respiratory infections in the developing world: respiratory syncytial virus and parainfluenza viruses. Rev Infect Dis 13(Suppl 6), S492-S500.
18. T Roger, P Bresser, M Snoek, et al. (2004) Exaggerated IL-8 and IL-6 responses to TNF-alpha by parainfluenza virus type 4-infected NCI-H292 cells. Am J Physiol Lung Cell Mol Physiol 287 L1048-L1055.
19. XY Mo, SR Sarawar and PC Doherty (1995) Induction of cytokines in mice with parainfluenza pneumonia. J Virol 69 1288-1291.
20. RE El Feghaly, L McGann, CA Bonville, et al. (2010) Local production of inflammatory mediators during childhood parainfluenza virus infection. Pediatr Infect Dis J 29 e26-e31.
21. CB Hall, RG Douglas Jr, RL Simons and JM Geiman (1978) Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections. J Pediatr 93 28-32.
22. CA Bonville, HF Rosenberg and JB Domachowske (1999) Macrophage inflammatory protein-1alpha and RANTES are present in nasal secretions during ongoing upper respiratory tract infection. Pediatr Allergy Immunol 10 39-44.
23. MB Elliott, RC Welliver Sr, TS Laughlin, et al. (2007) Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection. J Med Virol 79 447-456.
24. S Sieg, C King, Y Huang and D Kaplan (1996) The role of interleukin-10 in the inhibition of T-cell proliferation and apoptosis mediated by parainfluenza virus type 3. J Virol 70 4845-4848.
25. M do Carmo Debur, SM Raboni, FB Flizikowski, et al. (2010) Immunohistochemical assessment of respiratory viruses in necropsy samples from lethal non-pandemic seasonal respiratory infections. J Clin Pathol 63 930-934.
26. CB Hall (2001) Respiratory syncytial virus and parainfluenza virus. N Engl J Med 344 1917-1928.
27. CB Smith, RH Purcell, JA Bellanti and RM Chanock (1966) Protective effect of antibody to parainfluenza type 1 virus. N Engl J Med 275 1145-1152.
28. LP Tremonti, JS Lin and GG Jackson (1968) Neutralizing activity in nasal secretions and serum in resistance of volunteers to parainfluenza virus type 2. J Immunol 101 572-577.
29. R Yanagihara and K McIntosh (1980) Secretory immunological response in infants and children to parainfluenza virus types 1 and 2. Infect Immun 30 23-28.
30. RC Welliver, DT Wong, EJ Middleton, et al. (1982) Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J Pediatr 101 889-896.
31. RM Chanock, RH Parrott, KM Johnson, et al. (1963) Myxoviruses: parainfluenza. Am Rev Respir Dis 88 152-166. SUPPL
32. KL van Wyke Coelingh, C Winter and BR Murphy (1985) Antigenic variation in the hemagglutinin-neuraminidase protein of human parainfluenza type 3 virus. Virology 143 569-582.
33. WP Glezen, AL Frank, LH Taber and JA Kasel (1984) Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J Infect Dis 150 851-857.
34. R Welliver, DT Wong, TS Choi and PL Ogra (1982) Natural history of parainfluenza virus infection in childhood. J Pediatr 101 180-187.
35. FW Henderson (1979) Pulmonary cell-mediated cytotoxicity in hamsters with parainfluenza virus type 3 pneumonia. Am Rev Respir Dis 120 41-47.
36. S Hou, PC Doherty, M Zijlstra, et al. (1992) Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells. J Immunol 149 1319-1325.
37. RC Welliver, M Sun and D Rinaldo (1985) Defective regulation of immune responses in croup due to parainfluenza virus. Pediatr Res 19 716-720.
38. KJ Cortez, DD Erdman, TC Peret, et al. (2001) Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population. J Infect Dis 184 1093-1097.
39. RT Maziarz, P Sridharan, S Slater, et al. (2010) Control of an outbreak of human parainfluenza virus 3 in hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 16 192-198.
40. WG Nichols, DD Erdman, A Han, et al. (2004) Prolonged outbreak of human parainfluenza virus 3 infection in a stem cell transplant outpatient department: insights from molecular epidemiologic analysis. Biol Blood Marrow Transplant 10 58-64.
41. S Broor, S Parveen, P Bharaj, et al. (2007) A prospective three-year cohort study of the epidemiology and virology of acute respiratory infections of children in rural India. PLoS One 2 e491.
42. SS Malekshahi, TM Azad, J Yavarian, et al. (2010) Molecular detection of respiratory viruses in clinical specimens from children with acute respiratory disease in Iran. Pediatr Infect Dis J 29 931-933.
43. JE Stark, RB Heath and S Peto (1964) A study of the antibodies against parainfluenza viruses in children's sera. Arch Gesamte Virusforsch 14 160-168.
44. MS Lee, PM Mendelman, C Sangli, et al. (2001) Half-life of human parainfluenza virus type 3 (hPIV3) maternal antibody and cumulative proportion of hPIV3 infection in young infants. J Infect Dis 183 1281-1284.
45. JV Williams, KM Edwards, GA Weinberg, et al. (2010) Population-based incidence of human metapneumovirus infection among hospitalized children. J Infect Dis 201 1890-1898.
46. A Marx, TJ Torok, RC Holman, et al. (1997) Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics. J Infect Dis 176 1423-1427.
47. AO Segal, EJ Crighton, R Moineddin, et al. (2005) Croup hospitalizations in Ontario: a 14-year time-series analysis. Pediatrics 116 51-55.
48. KJ Henrickson, SM Kuhn and LL Savatski (1994) Epidemiology and cost of infection with human parainfluenza virus types 1 and 2 in young children. Clin Infect Dis 18 770-779.
49. WP Glezen, SB Greenberg, RL Atmar, et al. (2000) Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 283 499-505.
50. EE Walsh, AR Falsey and PA Hennessey (1999) Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. Am J Respir Crit Care Med 160 791-795.
51. AR Falsey, GE Dallal, MA Formica, et al. (2008) Long-term care facilities: a cornucopia of viral pathogens. J Am Geriatr Soc 56 1281-1285.
52. AL Frank, LH Taber, CR Wells, et al. (1981) Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis 144 433-441.
53. WS Miller and MS Artenstein (1967) Aerosol stability of three acute respiratory disease viruses. Proc Soc Exp Biol Med 125 222-227.
54. MT Brady, J Evans and J Cuartas (1990) Survival and disinfection of parainfluenza viruses on environmental surfaces. Am J Infect Control 18 18-23.
55. SA Ansari, VS Springthorpe, SA Sattar, et al. (1991) Potential role of hands in the spread of respiratory viral infections: studies with human parainfluenza virus 3 and rhinovirus 14. J Clin Microbiol 29 2115-2119.
56. RA Karron, KL O’Brien, JL Froehlich and VA Brown (1993) Molecular epidemiology of a parainfluenza type 3 virus outbreak on a pediatric ward. J Infect Dis 167 1441-1445.
57. SE Moisiuk, D Robson, L Klass, et al. (1998) Outbreak of parainfluenza virus type 3 in an intermediate care neonatal nursery. Pediatr Infect Dis J 17 49-53.
58. W Ng, VS Rajadurai, VK Pradeepkumar, et al. (1999) Parainfluenza type 3 viral outbreak in a neonatal nursery. Ann Acad Med Singapore 28 471-475.
59. A Piralla, E Percivalle, A Di Cesare-Merlone, et al. (2009) Multicluster nosocomial outbreak of parainfluenza virus type 3 infection in a pediatric oncohematology unit: a phylogenetic study. Haematologica 94 833-839.
60. FW Henderson, AM Collier, MA Sanyal, et al. (1982) A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N Engl J Med 306 1377-1383.
61. FW Denny, TF Murphy, WA Clyde Jr, et al. (1983) Croup: an 11-year study in a pediatric practice. Pediatrics 71 871-876.
62. H Laurichesse, D Dedman, JM Watson and MC Zambon (1999) Epidemiological features of parainfluenza virus infections: laboratory surveillance in England and Wales, 1975–1997. Eur J Epidemiol 15 475-484.
63. KJ Henrickson, S Hoover, KS Kehl and W Hua (2004) National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr Infect Dis J 23 S11-S118.
64. AM Knott, CE Long and CB Hall (1994) Parainfluenza viral infections in pediatric outpatients: seasonal patterns and clinical characteristics. Pediatr Infect Dis J 13 269-273.
65. Johnson D. Croup. Clin Evid (Online) 2009;2009.
66. JD Cherry (2008) Clinical practice. Croup. N Engl J Med 358 384-391.
67. M Salour (2000) The steeple sign. Radiology 216 428-429.
68. GM Loughlin and LM Taussig (1979) Pulmonary function in children with a history of laryngotracheobronchitis. J Pediatr 94 365-369.
69. D Gurwitz, M Corey and H Levison (1980) Pulmonary function and bronchial reactivity in children after croup. Am Rev Respir Dis 122 95-99.
70. R Chanock, L Chambon, W Chang, et al. (1967) WHO respiratory disease survey in children: a serological study. Bull World Health Organ 37 363-369.
71. C Calvo, F Pozo, ML Garcia-Garcia, et al. (2010) Detection of new respiratory viruses in hospitalized infants with bronchiolitis: a three-year prospective study. Acta Paediatr 99 883-887.
72. D Miron, I Srugo, Z Kra-Oz, et al. (2010) Sole pathogen in acute bronchiolitis: is there a role for other organisms apart from respiratory syncytial virus? Pediatr Infect Dis J 29 e7-e10.
73. F Freymuth, A Vabret, J Dina, et al. (2010) [Bronchiolitis viruses]. Arch Pediatr 17 1192-1201.
74. JV Williams, PA Harris, SJ Tollefson, et al. (2004) Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med 350 443-450.
75. RT Stein, D Sherrill, WJ Morgan, et al. (1999) Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354 541-545.
76. MK Hyvarinen, A Kotaniemi-Syrjanen, et al. (2005) Teenage asthma after severe early childhood wheezing: an 11-year prospective follow-up. Pediatr Pulmonol 40 316-323.
77. M Sokhandan, ER McFadden Jr, YT Huang and MB Mazanec (1995) The contribution of respiratory viruses to severe exacerbations of asthma in adults. Chest 107 1570-1574.
78. IC Michelow, K Olsen, J Lozano, et al. (2004) Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 113 701-707.
79. MN Tsolia, S Psarras, A Bossios, et al. (2004) Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis 39 681-686.
80. G Cilla, E Onate, EG Perez-Yarza, et al. (2008) Viruses in community-acquired pneumonia in children aged less than 3 years old: high rate of viral coinfection. J Med Virol 80 1843-1849.
81. CM Nascimento-Carvalho, CT Ribeiro, MR Cardoso, et al. (2008) The role of respiratory viral infections among children hospitalized for community-acquired pneumonia in a developing country. Pediatr Infect Dis J 27 939-941.
82. M Mathisen, TA Strand, P Valentiner-Branth, et al. (2010) Respiratory viruses in Nepalese children with and without pneumonia: a case-control study. Pediatr Infect Dis J 29 731-735.
83. JA Berkley, P Munywoki, M Ngama, et al. (2010) Viral etiology of severe pneumonia among Kenyan infants and children. JAMA 303 2051-2057.
84. KL Hon, TF Leung, KL Cheung, et al. (2010) Influenza and parainfluenza associated pediatric ICU morbidity. Indian J Pediatr 77 1097-1101.
85. SA Madhi, N Ramasamy, K Petersen, et al. (2002) Severe lower respiratory tract infections associated with human parainfluenza viruses 1–3 in children infected and noninfected with HIV type 1. Eur J Clin Microbiol Infect Dis 21 499-505.
86. CH Wendt, DJ Weisdorf, MC Jordan, et al. (1992) Parainfluenza virus respiratory infection after bone marrow transplantation. N Engl J Med 326 921-926.
87. JA Frank Jr, RW Warren, JA Tucker, et al. (1983) Disseminated parainfluenza infection in a child with severe combined immunodeficiency. Am J Dis Child 137 1172-1174.
88. VA Lewis, R Champlin, J Englund, et al. (1996) Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin Infect Dis 23 1033-1037.
89. WG Nichols, T Gooley and M Boeckh (2001) Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience. Biol Blood Marrow Transplant 7(Suppl), 11S-15S.
90. Y Bulut, M Guven, B Otlu, et al. (2007) Acute otitis media and respiratory viruses. Eur J Pediatr 166 223-228.
91. O Ruuskanen, M Arola, A Putto-Laurila, et al. (1989) Acute otitis media and respiratory virus infections. Pediatr Infect Dis J 8 94-99.
92. T Heikkinen and T Chonmaitree (2003) Importance of respiratory viruses in acute otitis media. Clin Microbiol Rev 16 230-241.
93. ES Arisoy, GJ Demmler, S Thakar and C Doerr (1993) Meningitis due to parainfluenza virus type 3: report of two cases and review. Clin Infect Dis 17 995-997.
94. D Wilks and SM Burns (1998) Myopericarditis associated with parainfluenza virus type 3 infection. Eur J Clin Microbiol Infect Dis 17 363-365.
95. G Roman, CA Phillips and CM Poser (1978) Parainfluenza virus type 3: isolation from CSF of a patient with Guillain-Barre syndrome. JAMA 240 1613-1615.
96. CS Greeley (2005) Sudden death from human parainfluenza virus 2. J Infect 50 366.
97. JR Lucas, EA Haas, H Masoumi and HF Krous (2009) Sudden death in a toddler with laryngotracheitis caused by human parainfluenza virus-1. Pediatr Dev Pathol 12 165-168.
98. MJ Stokes, MA Downham, JK Webb, et al. (1977) Viruses and febrile convulsions. Arch Dis Child 52 129-133.
99. BA Jantausch, BL Wiedermann and B Jeffries (1995) Parainfluenza virus type 2 meningitis and parotitis in an 11-year-old child. South Med J 88 230-231.
100. LM Zollar and MA Mufson (1970) Acute parotitis associated with parainfluenza 3 virus infection. Am J Dis Child 119 147-148.
101. T Jartti, L Jartti, V Peltola, et al. (2008) Identification of respiratory viruses in asymptomatic subjects: asymptomatic respiratory viral infections. Pediatr Infect Dis J 27 1103-1107.
102. T Heikkinen, J Marttila, AA Salmi and O Ruuskanen (2002) Nasal swab versus nasopharyngeal aspirate for isolation of respiratory viruses. J Clin Microbiol 40 4337-4339.
103. SK Lau, WK To, PW Tse, et al. (2005) Human parainfluenza virus 4 outbreak and the role of diagnostic tests. J Clin Microbiol 43 4515-4521.
104. DT Wong, RC Welliver, KR Riddlesberger, et al. (1982) Rapid diagnosis of parainfluenza virus infection in children. J Clin Microbiol 16 164-167.
105. GA Weinberg, DD Erdman, KM Edwards, et al. (2004) Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children. J Infect Dis 189 706-710.
106. J Kuypers, AP Campbell, A Cent, et al. (2009) Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients. Transpl Infect Dis 11 298-303.
107. AE Casiano-Colon, BB Hulbert, TK Mayer, et al. (2003) Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial virus infection in adults. J Clin Virol 28 169-174.
108. S Chakrabarti, KE Collingham, K Holder, et al. (2000) Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy. Clin Infect Dis 31 1516-1518.
109. WG Nichols, L Corey, T Gooley, et al. (2001) Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 98 573-578.
110. J Stankova, AS Carret, D Moore, et al. (2007) Long-term therapy with aerosolized ribavirin for parainfluenza 3 virus respiratory tract infection in an infant with severe combined immunodeficiency. Pediatr Transplant 11 209-213.
111. SY Park, H Sung, KT Park, et al. (2009) Parainfluenza virus 3 pneumonia in a kidney transplant recipient. Transpl Infect Dis 11 333-336.
112. V Liu, GS Dhillon and D Weill (2010) A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients. Transpl Infect Dis 12 38-44.
113. LH McCurdy, A Milstone and S Dummer (2003) Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin. J Heart Lung Transplant 22 745-753.
114. V Erard, JW Chien, HW Kim, et al. (2006) Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses. J Infect Dis 193 1619-1625.
115. M Boeckh (2008) The challenge of respiratory virus infections in hematopoietic cell transplant recipients. Br J Haematol 143 455-467.
116. E Whimbey, JA Englund and RB Couch (1997) Community respiratory virus infections in immunocompromised patients with cancer. Am J Med 102 10-18. discussion 25–6
117. SE Dorman, G Uzel, J Roesler, et al. (1999) Viral infections in interferon-gamma receptor deficiency. J Pediatr 135 640-643.
118. JC King Jr, AR Burke, JD Clemens, et al. (1993) Respiratory syncytial virus illnesses in human immunodeficiency virus- and noninfected children. Pediatr Infect Dis J 12 733-739.
119. SA Madhi, B Schoub, K Simmank, et al. (2000) Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1. J Pediatr 137 78-84.
120. M Sato and PF Wright (2008) Current status of vaccines for parainfluenza virus infections. Pediatr Infect Dis J 27 S123-S125.
121. J Chin, RL Magoffin, LA Shearer, et al. (1969) Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol 89 449-463.
122. RJ Brideau, NL Oien, DJ Lehman, et al. (1993) Protection of cotton rats against human parainfluenza virus type 3 by vaccination with a chimeric FHN subunit glycoprotein. J Gen Virol 74(Pt 3), 471-477.
123. RA Karron, PF Wright, FK Newman, et al. (1995) A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children. J Infect Dis 172 1445-1450.
124. RA Karron, PF Wright, SL Hall, et al. (1995) A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children. J Infect Dis 171 1107-1114.
125. DP Greenberg, RE Walker, MS Lee, et al. (2005) A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy. J Infect Dis 191 1116-1122.
126. EJ Bartlett, E Amaro-Carambot, SR Surman, et al. (2005) Human parainfluenza virus type I (HPIV1) vaccine candidates designed by reverse genetics are attenuated and efficacious in African green monkeys. Vaccine 23 4631-4646.
127. SM Nolan, SR Surman, E Amaro-Carambot, et al. (2005) Live-attenuated intranasal parainfluenza virus type 2 vaccine candidates developed by reverse genetics containing L polymerase protein mutations imported from heterologous paramyxoviruses. Vaccine 23 4765-4774.